ADARx Pharmaceuticals files for Nasdaq Global Market IPO under ADRX
ADARx Pharmaceuticals, a late-clinical stage siRNA therapeutics developer, filed for an initial public offering and plans to list on the Nasdaq Global Market under ticker ADRX.
Story updates
09:33:05 PM UTC
SquawkNews
Adarx Pharmaceuticals Announces Initial Public Offering Of Common Stock, SEC Filing
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.